Hims & Hers Health, Inc. (HIMS) Dividend History

Hims & Hers Health, Inc. is a telehealth company that offers a range of healthcare and wellness products and services. It provides virtual consultations, prescription medications, and over-the-counter wellness products across categories such as mental health, dermatology, sexual health, and primary care, aiming to improve access and convenience in healthcare delivery.

2269 Chestnut St, San Francisco, CA, 94123
Phone: 415-851-0195
Website:

Dividend History

Hims & Hers Health, Inc. currently does not pay dividends

Company News

  • Hims & Hers Stock: Buy the Dip or Wait It Out?

    Hims & Hers Health (HIMS) is considering acquiring a European company, Zava, to expand its digital healthcare business. However, this move has raised concerns among investors due to increased regulation and geopolitical tensions between the US and EU, leading to a drop in the stock price. Analysts suggest waiting for a better entry point around $30-$32 per share to mitigate the short-term risks.

    Investing.com
  • Hims & Hers Goes on a Buying Spree

    Hims & Hers, a healthcare company, is using its recent $1 billion capital raise to acquire ZAVA, a European healthcare company. This acquisition is expected to keep Hims & Hers' revenue growing at an incredible pace.

    The Motley Fool
  • 3 Surprising Stocks That Have More Than Doubled in 2025

    Hims & Hers Health, FuboTV, and Groupon have all more than doubled their stock prices so far in 2025, despite facing various challenges. Hims & Hers benefited from the semaglutide compounding loophole, FuboTV struck a deal with Disney, and Groupon is starting to turn the corner after years of declining revenue.

    The Motley Fool
    Featured Companies: FUBO GRPN
  • Super Micro Computer, Hims & Hers And Aurora Innovation Are Among Top 10 Large-Cap Losers Last Week (May 19-May 23): Are The Others In Your Portfolio?

    Several large-cap companies, including Super Micro Computer, Hims & Hers Health, and Aurora Innovation, experienced significant losses last week. The article discusses the reasons behind the stock declines, such as regulatory concerns, earnings reports, and industry developments.

    Benzinga
    Featured Companies: AUR BAH BURL CPRT DECK FICO FSLR NVDA ROST SMCI TPL UBER WDAY
  • Will Hims & Hers Stock Be Okay After UnitedHealth's Sell-Off?

    Hims & Hers Health Inc (HIMS) stock appears to be relatively unaffected by the recent sell-off in UnitedHealth Group (UNH) stock. Hims & Hers' business model, combining medical stability and technological innovation, could make it resilient to industry-wide volatility.

    Investing.com
    Featured Companies: UNH
Dividend data last updated 06/07/2025 04:01:45 UTC